These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 31542979)
1. An oncogenic activity of PDGF-C and its splice variant in human breast cancer. Bottrell A; Meng YH; Najy AJ; Hurst N; Kim S; Kim CJ; Kim ES; Moon A; Kim EJ; Park SY; Kim HC Growth Factors; 2019 Aug; 37(3-4):131-145. PubMed ID: 31542979 [TBL] [Abstract][Full Text] [Related]
2. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways. Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844 [TBL] [Abstract][Full Text] [Related]
3. Platelet-derived growth factor-C (PDGF-C) activation by serine proteases: implications for breast cancer progression. Hurst NJ; Najy AJ; Ustach CV; Movilla L; Kim HR Biochem J; 2012 Feb; 441(3):909-18. PubMed ID: 22035541 [TBL] [Abstract][Full Text] [Related]
4. Identification and expression analysis of an N-terminally truncated isoform of human PDGF-C. Zhao J; Liu Z; Liu T; Nilsson S; Nistér M Exp Cell Res; 2008 Aug; 314(14):2529-43. PubMed ID: 18588873 [TBL] [Abstract][Full Text] [Related]
5. PDGF-D improves drug delivery and efficacy via vascular normalization, but promotes lymphatic metastasis by activating CXCR4 in breast cancer. Liu J; Liao S; Huang Y; Samuel R; Shi T; Naxerova K; Huang P; Kamoun W; Jain RK; Fukumura D; Xu L Clin Cancer Res; 2011 Jun; 17(11):3638-48. PubMed ID: 21459800 [TBL] [Abstract][Full Text] [Related]
6. Matriptase activation and shedding through PDGF-D-mediated extracellular acidosis. Najy AJ; Dyson G; Jena BP; Lin CY; Kim HR Am J Physiol Cell Physiol; 2016 Feb; 310(4):C293-304. PubMed ID: 26157007 [TBL] [Abstract][Full Text] [Related]
7. Downregulation of PDGF-D Inhibits Proliferation and Invasion in Breast Cancer MDA-MB-231 Cells. Lu JF; Hu ZQ; Yang MX; Liu WY; Pan GF; Ding JB; Liu JZ; Tang L; Hu B; Li HC Clin Breast Cancer; 2022 Feb; 22(2):e173-e183. PubMed ID: 34272173 [TBL] [Abstract][Full Text] [Related]
8. Post-transcriptional up-regulation of PDGF-C by HuR in advanced and stressed breast cancer. Luo NA; Qu YQ; Yang GD; Wang T; Li RL; Jia LT; Dong R Int J Mol Sci; 2014 Nov; 15(11):20306-20. PubMed ID: 25383675 [TBL] [Abstract][Full Text] [Related]
9. Platelet-derived growth factor-C (PDGF-C) induces anti-apoptotic effects on macrophages through Akt and Bad phosphorylation. Son D; Na YR; Hwang ES; Seok SH J Biol Chem; 2014 Feb; 289(9):6225-35. PubMed ID: 24421315 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of platelet-derived growth factor C and their receptors additionally increases doxorubicin effects in triple-negative breast cancer cells. Kim S; You D; Jeong Y; Yoon SY; Kim SA; Lee JE Eur J Pharmacol; 2021 Mar; 895():173868. PubMed ID: 33460613 [TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor D is activated by urokinase plasminogen activator in prostate carcinoma cells. Ustach CV; Kim HR Mol Cell Biol; 2005 Jul; 25(14):6279-88. PubMed ID: 15988036 [TBL] [Abstract][Full Text] [Related]
12. A novel signaling axis of matriptase/PDGF-D/ß-PDGFR in human prostate cancer. Ustach CV; Huang W; Conley-LaComb MK; Lin CY; Che M; Abrams J; Kim HR Cancer Res; 2010 Dec; 70(23):9631-40. PubMed ID: 21098708 [TBL] [Abstract][Full Text] [Related]
13. The PDGF pathway in breast cancer is linked to tumour aggressiveness, triple-negative subtype and early recurrence. Jansson S; Aaltonen K; Bendahl PO; Falck AK; Karlsson M; Pietras K; Rydén L Breast Cancer Res Treat; 2018 Jun; 169(2):231-241. PubMed ID: 29380207 [TBL] [Abstract][Full Text] [Related]
14. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282 [TBL] [Abstract][Full Text] [Related]
15. Platelet-derived growth factor-C and -D in the cardiovascular system and diseases. Lee C; Li X Mol Aspects Med; 2018 Aug; 62():12-21. PubMed ID: 28965749 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma. Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327 [TBL] [Abstract][Full Text] [Related]
17. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway. Zhang H; Sun JD; Yan LJ; Zhao XP Biochem Biophys Res Commun; 2016 Sep; 478(2):845-51. PubMed ID: 27507215 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition in breast cancer lines is mediated through PDGF-D released by tissue-resident stem cells. Devarajan E; Song YH; Krishnappa S; Alt E Int J Cancer; 2012 Sep; 131(5):1023-31. PubMed ID: 22038895 [TBL] [Abstract][Full Text] [Related]
19. PDGF C is a selective alpha platelet-derived growth factor receptor agonist that is highly expressed in platelet alpha granules and vascular smooth muscle. Fang L; Yan Y; Komuves LG; Yonkovich S; Sullivan CM; Stringer B; Galbraith S; Lokker NA; Hwang SS; Nurden P; Phillips DR; Giese NA Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):787-92. PubMed ID: 15061151 [TBL] [Abstract][Full Text] [Related]
20. Structural requirements for activation of latent platelet-derived growth factor CC by tissue plasminogen activator. Fredriksson L; Ehnman M; Fieber C; Eriksson U J Biol Chem; 2005 Jul; 280(29):26856-62. PubMed ID: 15911618 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]